These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7579490)

  • 1. Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer.
    Iglehart JD; Kerns BJ; Huper G; Marks JR
    Breast Cancer Res Treat; 1995 Jun; 34(3):253-63. PubMed ID: 7579490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast.
    Maguire HC; Hellman ME; Greene MI; Yeh I
    Pathobiology; 1992; 60(3):117-21. PubMed ID: 1352687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues.
    Kobayashi M; Ooi A; Oda Y; Nakanishi I
    Hum Pathol; 2002 Jan; 33(1):21-8. PubMed ID: 11823970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.
    Tsuda H; Iwaya K; Fukutomi T; Hirohashi S
    Jpn J Cancer Res; 1993 Apr; 84(4):394-401. PubMed ID: 8099903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
    Park K; Han S; Kim HJ; Kim J; Shin E
    Histopathology; 2006 May; 48(6):702-7. PubMed ID: 16681686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-erbB-2 oncogene in breast cancer: the right target or a decoy?
    Anderson TJ
    Hum Pathol; 1992 Sep; 23(9):971-3. PubMed ID: 1355463
    [No Abstract]   [Full Text] [Related]  

  • 11. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia.
    Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM
    Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.
    Allred DC; Clark GM; Molina R; Tandon AK; Schnitt SJ; Gilchrist KW; Osborne CK; Tormey DC; McGuire WL
    Hum Pathol; 1992 Sep; 23(9):974-9. PubMed ID: 1355464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
    Somerville JE; Clarke LA; Biggart JD
    J Clin Pathol; 1992 Jan; 45(1):16-20. PubMed ID: 1346789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
    Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
    J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach.
    Ridolfi RL; Jamehdor MR; Arber JM
    Mod Pathol; 2000 Aug; 13(8):866-73. PubMed ID: 10955453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Her-2 amplification and p185 expression in invasive breast cancer cells in women].
    Titi S
    Ann Acad Med Stetin; 2006; 52(2):5-12. PubMed ID: 17633393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.
    Lambein K; Van Bockstal M; Vandemaele L; Van den Broecke R; Cocquyt V; Geenen S; Denys H; Libbrecht L
    Virchows Arch; 2017 Nov; 471(5):575-587. PubMed ID: 28567637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutations and expression in breast carcinoma in situ.
    Lukas J; Niu N; Press MF
    Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.